Few phrases are more capable of commanding the world’s attention than “possible plague outbreak.”
So when a laboratory worker at a Russian facility dedicated to studying dangerous pathogens died under mysterious circumstances, speculation about just such an outbreak quickly spread online. The incident, which occurred in Siberia, prompted quarantines, international scrutiny, and questions about what exactly happened inside the lab.
To be clear, there is no confirmed plague outbreak, nor is there any publicly substantiated evidence that the facility was conducting gain-of-function experiments or engaged in unlawful research.
Nevertheless, speculation about a possible laboratory accident, coupled with lingering questions about the circumstances surrounding the worker’s death, has brought renewed attention to the risks associated with studying dangerous pathogens.
It also offers an opportunity to salute the Trump administration for its efforts to restrict taxpayer funding for dangerous gain-of-function research.
A mysterious death in Siberia
According to reporting by Reuters, Darya Shipilova, a 28-year-old employee of the Irkutsk Anti-Plague Research Institute, died October 2 after developing a severe respiratory illness. Her death prompted Russian authorities to quarantine or monitor approximately 200 people.
Reuters also described unconfirmed reports suggesting Shipilova may have been exposed to plague bacteria in a laboratory accident. Russian authorities have denied any connection between her death and her work, attributing her illness to pneumonia of undetermined origin.
On October 8, Reuters reported that Russian officials had completed their monitoring efforts and found no dangerous pathogens in nearly 5,000 samples. Nevertheless, public health officials and organizations worldwide continued seeking additional information about the circumstances of Shipilova’s death.
History also illustrates why international health officials place such a premium on transparency during public-health scares. In an infamous case from 1979, Soviet authorities concealed the true cause of an anthrax outbreak in Sverdlovsk, initially blaming contaminated meat rather than an accidental release from a military biological facility. A 1994 study published in Science subsequently confirmed that the outbreak originated from an airborne release at the facility.
Of course, history alone cannot establish what happened in Irkutsk.
A sensible precaution
Whatever ultimately emerges from Siberia, the episode raises a larger question: How much risk should society tolerate in the pursuit of scientific knowledge?
The risks involved in studying naturally occurring pathogens are one thing. They become an entirely different consideration when scientists deliberately modify infectious agents to make them more dangerous.
Enter gain-of-function research.
The term encompasses a broad range of scientific experiments, but the most controversial involve increasing a pathogen’s transmissibility, virulence, or ability to evade existing defenses.
Although scientists have employed gain-of-function techniques for decades, some of the more controversial applications came under intense international scrutiny in 2011 and 2012, when researchers demonstrated that the H5N1 bird flu virus could be genetically modified to spread through the air between ferrets, animals commonly used to study influenza transmission in humans.
Supporters argue that certain experiments can help scientists anticipate emerging threats, understand disease transmission, and develop vaccines or treatments.
But the importance of those objectives hardly settles whether every potentially informative experiment is worth conducting, much less whether American taxpayers should finance it.
There is, after all, an obvious difference between studying a dangerous pathogen and deliberately making one more dangerous in hopes of learning how to defeat it.
And the consequences of getting it wrong could be catastrophic.
Kudos to the Trump administration
In May 2025, President Donald Trump signed an executive order directing federal agencies to suspend support for dangerous gain-of-function research and terminate certain high-risk projects overseas.
The administration went further in July 2026, announcing a new government-wide policy explicitly prohibiting federal support for research meeting its definition of dangerous gain-of-function experimentation, while strengthening oversight of other high-risk biological research.
Importantly, the policy preserves federal support for biomedical research, including the development of vaccines, treatments, and diagnostic tools, subject to appropriate safeguards.
On the whole, this was a recognition that the federal government has a responsibility to weigh the potential benefits of dangerous experimentation against the consequences of something going terribly wrong.
It also established a sensible boundary: American taxpayers should not be expected to underwrite experiments that could create extraordinary biological risks.
Whatever conclusion ultimately emerges from Siberia, the recent scare has brought questions about the risks of biological research back into the public conversation.
Scientific discovery matters enormously. So does ensuring that the pursuit of knowledge does not create more danger than it promises to eliminate. The Trump administration deserves credit for recognizing that distinction and acting on it.
The latest findings suggest that the alarming reports of a plague outbreak in Siberia were unfounded. For everyone’s sake, that’s welcome news.
But the broader lesson remains: When the consequences of a scientific mistake could extend far beyond laboratory walls, caution is not an obstacle to progress.
It is a prerequisite for responsible science.
Editor’s note:
Those interested in this topic more broadly should read Biological War: A Scenario, a timely book written by the journalist Annie Jacobsen. Full disclosure: It may cause you to lose a little sleep.